Gene expression analysis of peripheral blood in patients with RA pre- and post-TOFA therapy revealed a significantly higher expression of the SDHB and PKM2 genes in both subgroups of patients than in healthy subjects both before and after TOFA treatment. Here, PKM is linked to rheumatoid arthritis.